Last reviewed · How we verify
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion (THEIA)
The aim of the THEIA study is to determine if Alteplase administrated within 4.5 hours improve visual deficit due to acute CRAO with a good safety profile.
Details
| Lead sponsor | Nantes University Hospital |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 70 |
| Start date | Fri Jun 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Central Retinal Artery Occlusion
Interventions
- Alteplase
- acetylsalicylic acid
- Placebo Oral Tablet
- placebo IV
Countries
France